Dna encoding snorf25 receptor
CA 2362906 A1 · Owner: Boyle, Noel · Inventors: Thompson, Thelma O.; Borowsky, Beth E.; Adham, Nika
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides isolated nucleic acids encoding mammalian SNORF25 receptors, purified mammalian SNORF25 receptors vectors comprising nucleic , acid encoding mammalian SNORF25 receptors cells comprising such vectors, antibodies directed to mammalian SNORF25 receptors nucleic acid probes useful , for detecting nucleic acid encoding mammalian SNORF25 receptors antisense , oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF25 receptors, transgenic nonhuman animals which express DNA , encoding normal or mutant mammalian SNORF25 receptors methods of isolating , mammalian SNORF25 receptors methods of treating an abnormality that is linked to the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 22, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 22, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 22, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.